Bio-Rad Laboratories Inc (BIO)
350.23
-12.97
(-3.57%)
USD |
NYSE |
Nov 14, 16:00
351.79
+1.56
(+0.45%)
Pre-Market: 07:08
Bio-Rad Laboratories Cash from Operations (Quarterly): 163.61M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 163.61M |
| June 30, 2024 | 97.65M |
| March 31, 2024 | 69.79M |
| December 31, 2023 | 81.05M |
| September 30, 2023 | 97.71M |
| June 30, 2023 | 98.07M |
| March 31, 2023 | 98.12M |
| December 31, 2022 | 79.66M |
| September 30, 2022 | 11.03M |
| June 30, 2022 | 53.27M |
| March 31, 2022 | 50.49M |
| December 31, 2021 | 170.87M |
| September 30, 2021 | 230.36M |
| June 30, 2021 | 154.62M |
| March 31, 2021 | 113.61M |
| December 31, 2020 | 294.38M |
| September 30, 2020 | 135.66M |
| June 30, 2020 | 92.12M |
| March 31, 2020 | 62.81M |
| December 31, 2019 | 159.80M |
| September 30, 2019 | 99.75M |
| June 30, 2019 | 155.40M |
| March 31, 2019 | 42.94M |
| December 31, 2018 | 105.01M |
| September 30, 2018 | 62.28M |
| Date | Value |
|---|---|
| June 30, 2018 | 77.86M |
| March 31, 2018 | 40.35M |
| December 31, 2017 | 69.36M |
| September 30, 2017 | 28.48M |
| June 30, 2017 | 62.50M |
| March 31, 2017 | -56.20M |
| December 31, 2016 | 94.75M |
| September 30, 2016 | 51.61M |
| June 30, 2016 | 77.16M |
| March 31, 2016 | -7.448M |
| December 31, 2015 | 35.95M |
| September 30, 2015 | 82.28M |
| June 30, 2015 | 38.53M |
| March 31, 2015 | 29.45M |
| December 31, 2014 | 40.22M |
| September 30, 2014 | 90.65M |
| June 30, 2014 | 76.87M |
| March 31, 2014 | 65.57M |
| December 31, 2013 | 70.55M |
| September 30, 2013 | 54.83M |
| June 30, 2013 | 19.74M |
| March 31, 2013 | 24.02M |
| December 31, 2012 | 86.24M |
| September 30, 2012 | 71.34M |
| June 30, 2012 | 73.64M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
11.03M
Minimum
Sep 2022
294.38M
Maximum
Dec 2020
115.73M
Average
97.89M
Median
Cash from Operations (Quarterly) Benchmarks
| Agilent Technologies Inc | 452.00M |
| Bruker Corp | 38.40M |
| Azenta Inc | 1.791M |
| Harvard Bioscience Inc | -0.842M |
| Bionano Genomics Inc | -20.98M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -55.64M |
| Cash from Financing (Quarterly) | -95.99M |
| Free Cash Flow | 223.75M |
| Free Cash Flow Per Share (Quarterly) | 3.572 |
| Free Cash Flow to Equity (Quarterly) | 88.91M |
| Free Cash Flow to Firm (Quarterly) | 99.97M |
| Free Cash Flow Yield | 2.25% |